The endocannabinoid system is one of the most diffuse neurotransmitter systems in the body and the brain. Understanding its ...

If approved, it would be the first major new drug treatment for Parkinson’s in half a century. Richard Mailman, a University ...

Some guys are getting this promising new weight loss drug on the grey market. Here's what it does and the risks of taking it ...

Elinzanetant belongs to a new class of drugs designed to target what is believed to be a key mechanism responsible for ...

Sean Virani, MD, lead author of the new guidelines and president of the CCS, explained that the guidelines use the term ...

Cancer immunotherapy, especially using T cells, is showing a lot of promise in treating blood cancers. Bioengineered T cells, ...

Deciphering how the GR forms oligomers—through the binding of several subunits—opens a crucial avenue for developing more ...

Catnip's active compound, nepetalactone, triggers a euphoric response in cats by activating their brain's opioid reward ...

Study sets stage for development of synthetic biosensors with custom-built sensing and responses for basic and translational cell engineering applications.

Patients with obesity and asthma who used GLP-1 receptor agonists had significantly fewer exacerbations and prednisone use ...

Drugs to treat inflammatory and autoimmune diseases - such as asthma, psoriasis, rheumatoid arthritis or Chrousos syndrome - ...

"We've greatly misjudged and mis-prioritized the mental health of mothers in general and we've gotten a lot of it wrong." ...